Mounjaro, containing tirzepatide, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by promoting fat loss, blocking fat gain, regulating and blood sugar, and slowing digestion, which supports substantial weight loss when combined with a reduced-calorie diet and exercise. Clinical trials show patients can lose up to 20.9% of their body weight on the highest dose [2].Mounjaro is administered as a weekly injection, starting at a low dose (2.5 mg) and gradually increasing to a maintenance dose of up to 15 mg. Consistency in use and following healthcare provider instructions are crucial for achieving optimal results.You may be eligible for Mounjaro if your BMI is 30 or above, or 27+ with a weight-related health condition (such as high blood pressure or PCOS). You can speak to a Juniper prescriber by clicking the ‘Am I eligible?’ button to find the right treatment for you.